Early rhythm control reduces events in AF, trial shows
The results could change clinical practice, leading cardiologist says
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/cardio_articleimage_plainopt3_912x684px_1-1.png)
AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.
Initiation of rhythm-control therapy is associated with a lower risk of cardiovascular events and deaths than usual care among patients with early atrial fibrillation (AF) and multiple risk factors, a trial shows.